Top Chinese Stocks To Watch Now – November 16th

Diageo, UP Fintech, Regencell Bioscience, RBB Bancorp, China SXT Pharmaceuticals, BGM Group, and Hf Foods Group are the seven Chinese stocks to watch today, according to MarketBeat’s stock screener tool. “Chinese stocks” generally refers to shares of companies based in or closely tied to China, including those listed on mainland Chinese exchanges, Hong Kong, or overseas markets. For investors, the term can encompass different share classes and markets, each with its own rules, risks, and access requirements. These companies had the highest dollar trading volume of any Chinese stocks within the last several days.

Diageo (DEO)

Diageo plc, together with its subsidiaries, engages in the production, marketing, and sale of alcoholic beverages. The company offers scotch, gin, vodka, rum, raki, liqueur, wine, tequila, Chinese white spirits, cachaça, and brandy, as well as beer, including cider and flavored malt beverages. It also provides Chinese, Canadian, Irish, American, and Indian-Made Foreign Liquor whiskies, as well as flavored malt beverages, ready to drink, and non-alcoholic products.

NYSE:DEO traded up $0.77 during trading hours on Monday, hitting $102.36. The stock had a trading volume of 345,548 shares, compared to its average volume of 1,430,237. The business has a 50 day simple moving average of $90.96 and a two-hundred day simple moving average of $86.36. Diageo has a 1-year low of $72.45 and a 1-year high of $102.74. The company has a quick ratio of 0.62, a current ratio of 1.60 and a debt-to-equity ratio of 1.53.

Read Our Latest Research Report on DEO

UP Fintech (TIGR)

UP Fintech Holding Limited provides online brokerage services focusing on Chinese investors. The company has developed a brokerage platform, which allows investor to trade stocks, options, warrants, and other financial instruments that can be accessed through its APP and website. It offers brokerage and value-added services, including investor education, community engagement, and IR platform services.

Shares of NASDAQ TIGR traded down $0.10 during trading on Monday, reaching $4.04. 821,853 shares of the stock were exchanged, compared to its average volume of 3,062,004. The company has a market capitalization of $767.33 million, a price-to-earnings ratio of 6.84 and a beta of 0.65. The business’s 50-day moving average price is $4.36 and its 200 day moving average price is $5.61. The company has a quick ratio of 1.10, a current ratio of 1.10 and a debt-to-equity ratio of 0.06. UP Fintech has a twelve month low of $3.61 and a twelve month high of $11.35.

Read Our Latest Research Report on TIGR

Regencell Bioscience (RGC)

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.

Regencell Bioscience stock traded down $0.26 during midday trading on Monday, hitting $4.68. 50,306 shares of the stock were exchanged, compared to its average volume of 290,205. Regencell Bioscience has a 1 year low of $4.51 and a 1 year high of $69.00. The company has a 50 day moving average price of $6.79 and a two-hundred day moving average price of $16.00.

Read Our Latest Research Report on RGC

RBB Bancorp (RBB)

RBB Bancorp operates as the bank holding company for Royal Business Bank that provides various banking products and services to the Chinese-American, Korean-American, and other Asian-American communities. Its deposit products include checking, savings, and money market accounts, as well as certificates of deposit.

NASDAQ:RBB traded down $0.24 on Monday, reaching $25.75. The stock had a trading volume of 8,145 shares, compared to its average volume of 112,235. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.52. The company has a 50-day moving average of $26.18 and a 200 day moving average of $24.61. The stock has a market cap of $430.20 million, a P/E ratio of 9.98 and a beta of 1.06. RBB Bancorp has a 12-month low of $18.45 and a 12-month high of $28.24.

Read Our Latest Research Report on RBB

China SXT Pharmaceuticals (SXTC)

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.

Shares of NASDAQ SXTC traded down $0.14 during midday trading on Monday, reaching $2.87. 29,287 shares of the company’s stock were exchanged, compared to its average volume of 70,364. China SXT Pharmaceuticals has a 52-week low of $2.71 and a 52-week high of $8,375,880.00. The company has a quick ratio of 7.76, a current ratio of 7.94 and a debt-to-equity ratio of 0.02. The business’s fifty day moving average price is $114.33 and its two-hundred day moving average price is $10,872.08.

Read Our Latest Research Report on SXTC

BGM Group (BGM)

Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions.

Shares of NASDAQ:BGM traded down $0.17 during trading on Monday, hitting $7.71. The company’s stock had a trading volume of 5,681 shares, compared to its average volume of 9,416. BGM Group has a fifty-two week low of $6.45 and a fifty-two week high of $283.20. The stock’s 50-day moving average price is $8.52 and its two-hundred day moving average price is $15.11.

Read Our Latest Research Report on BGM

Hf Foods Group (HFFG)

HF Foods Group Inc., through its subsidiaries, markets and distributes Asian specialty food, seafood, fresh produce, frozen and dry food, and non-food products to Asian and Chinese restaurants, and other foodservice customers in the United States. The company offers seafood, including lobsters, shrimp, crabs, scallops, and fish; Asian specialty food items, including noodles, rice, dried mushrooms and beans, sauces and seasonings, and spring rolls, as well as canned products, such as preserved vegetables, bamboo shoots, and water chestnuts; and meat and poultry products, including beef, pork, chicken, and duck.

NASDAQ HFFG traded up $0.01 during mid-day trading on Monday, reaching $1.56. 23,724 shares of the company’s stock traded hands, compared to its average volume of 182,449. The company has a current ratio of 1.09, a quick ratio of 0.46 and a debt-to-equity ratio of 0.69. Hf Foods Group has a 1-year low of $1.38 and a 1-year high of $2.79. The company has a fifty day simple moving average of $1.56 and a 200-day simple moving average of $1.76. The company has a market cap of $87.02 million, a price-to-earnings ratio of -2.20, a P/E/G ratio of 0.81 and a beta of 0.58.

Read Our Latest Research Report on HFFG

Recommended Stories